Depletion of mitochondrial enzyme system in liver, lung, brain, stomach and kidney induced by benzo(a)pyrene.
TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells.
A novel NF-κB/YY1/microRNA-10a regulatory circuit in fibroblast-like synoviocytes regulates inflammation in rheumatoid arthritis.
Disturbance of Bcl-2, Bax, Caspase-3, Ki-67 and C-myc expression in acute and subchronic exposure to benzo(a)pyrene in cervix.
Subchronic exposure of benzo(a)pyrene interferes with the expression of Bcl-2, Ki-67, C-myc and p53, Bax, Caspase-3 in sub-regions of cerebral cortex and hippocampus.
Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro.
Recombinant mutated human TNF in combination with chemotherapy for stage IIIB/IV non-small cell lung cancer: a randomized, phase III study.
A pH-induced, intein-mediated expression and purification of recombinant human epidermal growth factor in Escherichia coli.
FOXP3 suppresses breast cancer metastasis through downregulation of CD44.
Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.
miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD.
The discoidin domain receptor 2/annexin A2/matrix metalloproteinase 13 loop promotes joint destruction in arthritis through promoting migration and invasion of fibroblast-like synoviocytes.
Lymphocyte oxidative stress/genotoxic effects are related to serum IgG and IgA levels in coke oven workers.
Recombinant IFN-α2a-NGR exhibits higher inhibitory function on tumor neovessels formation compared with IFN-α2a in vivo and in vitro.
Expression, purification and characterization of galectin-1 in Escherichia coli.
Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis.
Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression.
Impact of AhR, CYP1A1 and GSTM1 genetic polymorphisms on TP53 R273G mutations in individuals exposed to polycyclic aromatic hydrocarbons.
Synergistic increase of oxidative stress and tumor markers in PAH-exposed workers.
FOXP3 inhibits NF-κB activity and hence COX2 expression in gastric cancer cells.
UXT is a novel regulatory factor of regulatory T cells associated with Foxp3.
A novel dimeric thymosin beta 4 with enhanced activities accelerates the rate of wound healing.
Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.
miR-99b-targeted mTOR induction contributes to irradiation resistance in pancreatic cancer.
Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development.
High level expression, purification and characterization of recombinant CCR5 as a vaccine candidate against HIV.
Construction, expression, and characterization of thymosin alpha 1 tandem repeats in Escherichia coli.
Identification of a novel peptide ligand of human transfrrin receptor 1 for targeted tumor delivery drug.
Stromal cell-derived factor-1 (SDF-1)/CXCR4 axis enhances cellular invasion in ovarian carcinoma cells via integrin β1 and β3 expressions.
TNFα induced FOXP3-NFκB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells.
Stable plastid transformation for high-level recombinant protein expression: promises and challenges.
Phase II multicenter, randomized, double-blind study of recombinant mutated human tumor necrosis factor-α in combination with chemotherapies in cancer patients.
Microbiota downregulates dendritic cell expression of miR-10a, which targets IL-12/IL-23p40.
Expression, purification and characterization of a novel soluble human thymosin alpha1 concatemer exhibited a stronger stimulation on mice lymphocytes proliferation and higher anti-tumor activity.
Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity.
The preventive effect of adjuvant-free administration of TNF-PADRE autovaccine on collagen-II-induced rheumatoid arthritis in mice.
Amelioration of experimental autoimmune encephalomyelitis by BLyS autovaccine.
Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor.
Identification of a novel peptide ligand of human vascular endothelia growth factor receptor 3 for targeted tumour diagnosis and therapy.
Prepared and screened a modified TNF-alpha molecule as TNF-alpha autovaccine to treat LPS induced endotoxic shock and TNF-alpha induced cachexia in mouse.
Development of a mimotope-based vaccine against CD20 antigen.
Construction, purification, and immunogenicity of recombinant cystein-cystein type chemokine receptor 5 vaccine.
Production and purification of recombinant human BLyS mutant from inclusion bodies.
Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats.
Human vascular endothelial growth factor receptor 3 binding peptide and screening method thereof
Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule
Soluble human program death protein-1-lgV and preparation method thereof